OTC Markets EXMKT - Delayed Quote USD
American Bio Medica Corporation (ABMC)
0.0001
0.0000
(0.00%)
At close: May 22 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
726
913
2,218
4,147
Cost of Revenue
873
1,106
1,670
2,909
Gross Profit
-57
-103
548
1,238
Operating Expense
1,066
1,139
1,727
1,859
Operating Income
-1,123
-1,242
-1,179
-621
Net Non Operating Interest Income Expense
-164
-191
-194
-175
Other Income Expense
172
25
912
2
Pretax Income
852
-1,408
-461
-794
Tax Provision
2
2
2
2
Net Income Common Stockholders
850
-1,410
-463
-796
Diluted NI Available to Com Stockholders
850
-1,410
-463
-796
Basic EPS
0.02
-0.03
-0.01
-0.02
Diluted EPS
0.02
-0.03
-0.01
-0.02
Basic Average Shares
48,099.5980
48,017.6540
42,761.0650
35,558.1050
Diluted Average Shares
48,099.5980
48,017.6540
42,761.0650
35,558.1050
Total Operating Income as Reported
-1,123
-1,242
-1,179
-621
Total Expenses
1,939
2,245
3,397
4,768
Net Income from Continuing & Discontinued Operation
850
-1,410
-463
-796
Normalized Income
-2,177.8756
-1,410
-698
-796
Interest Income
0
3
0
--
Interest Expense
167
194
194
175
Net Interest Income
-164
-191
-194
-175
EBIT
1,019
-1,214
-267
-619
EBITDA
1,065
-1,163
-199
-540
Reconciled Cost of Revenue
873
1,106
1,670
2,909
Reconciled Depreciation
46
51
68
79
Net Income from Continuing Operation Net Minority Interest
850
-1,410
-463
-796
Total Unusual Items Excluding Goodwill
3,035
0
235
0
Total Unusual Items
3,035
0
235
0
Normalized EBITDA
-1,970
-1,163
-434
-540
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
7.1244
0
0
0
12/31/2020 - 2/1/1995
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade